Firms marketing dietary supplements in the US are picking up right where they left off before the COVID-19 pandemic with the types of good manufacturing practices the Food and Drug Administration is finding.
Supplement manufacturers, marketers and distributors also are making the same GMP mistakes most often, said Haijing Hu, branch chief for regulation in the FDA’s Office of
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?